trending Market Intelligence /marketintelligence/en/news-insights/trending/gvgm2s_pqn0ynzqf6xut4a2 content esgSubNav
In This List

Former GSK exec joins Aclaris Therapeutics as chief medical officer

Blog

Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet


Former GSK exec joins Aclaris Therapeutics as chief medical officer

Aclaris Therapeutics Inc. appointed David Gordon chief medical officer.

Gordon recently served as senior vice president and head of dermatology research at GlaxoSmithKline PLC.

Wayne, Pa.-based Aclaris Therapeutics develops therapies in the areas of medical and aesthetic dermatology as well as immunology.